Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Effect of Asundexian on Thrombotic Status, in Particular Endogenous Fibrinolysis, in Patients With Atrial Fibrillation

NCT06124612 is registered in ClinicalTrials.gov with East and North Hertfordshire NHS Trust as lead sponsor.

NCT NCT06124612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06124612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Effect of Asundexian on Thrombotic Status, in Particular Endogenous Fibrinolysis, in Patients With Atrial Fibrillation
Lead sponsor
East and North Hertfordshire NHS Trust
Phase
Observational
Overall status
Recruiting
Start date
November 3, 2023
Completion date
September 17, 2026
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation